Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Yeasts | 2 | 2017 | 50 | 1.35 | Why? |
| Decision Support Systems, Clinical | 2 | 2019 | 551 | 1.00 | Why? |
| Clinical Laboratory Information Systems | 1 | 2019 | 66 | 0.76 | Why? |
| Simplexvirus | 1 | 2019 | 124 | 0.72 | Why? |
| Herpesvirus 2, Human | 1 | 2019 | 137 | 0.70 | Why? |
| Mycobacterium Infections | 1 | 2017 | 72 | 0.65 | Why? |
| Phlebotomy | 1 | 2017 | 131 | 0.64 | Why? |
| Herpesvirus 3, Human | 1 | 2019 | 228 | 0.64 | Why? |
| Cost Savings | 1 | 2018 | 296 | 0.60 | Why? |
| Hemolysis | 1 | 2017 | 283 | 0.57 | Why? |
| Clinical Laboratory Services | 2 | 2019 | 781 | 0.57 | Why? |
| Volatile Organic Compounds | 1 | 2017 | 187 | 0.56 | Why? |
| AIDS-Related Opportunistic Infections | 1 | 2017 | 260 | 0.55 | Why? |
| Colorimetry | 1 | 2017 | 458 | 0.51 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 449 | 0.51 | Why? |
| Specimen Handling | 4 | 2021 | 6190 | 0.51 | Why? |
| Bacteria | 2 | 2017 | 1897 | 0.34 | Why? |
| Antigens, Fungal | 2 | 2019 | 106 | 0.34 | Why? |
| JC Virus | 1 | 2006 | 39 | 0.32 | Why? |
| Diagnostic Tests, Routine | 1 | 2018 | 2643 | 0.31 | Why? |
| Laboratories | 1 | 2019 | 2858 | 0.31 | Why? |
| Leukoencephalopathy, Progressive Multifocal | 1 | 2006 | 55 | 0.30 | Why? |
| False Negative Reactions | 3 | 2021 | 1785 | 0.29 | Why? |
| Clinical Decision-Making | 1 | 2019 | 3755 | 0.28 | Why? |
| Paragonimus | 1 | 2003 | 1 | 0.28 | Why? |
| Paragonimiasis | 1 | 2003 | 6 | 0.27 | Why? |
| Lung Diseases, Parasitic | 1 | 2003 | 17 | 0.27 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.27 | Why? |
| Viral Load | 4 | 2021 | 15850 | 0.26 | Why? |
| Cerebrospinal Fluid | 1 | 2004 | 234 | 0.24 | Why? |
| West Nile Fever | 1 | 2004 | 166 | 0.23 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.23 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.22 | Why? |
| HIV Infections | 2 | 2017 | 11620 | 0.21 | Why? |
| Polymerase Chain Reaction | 5 | 2019 | 6740 | 0.21 | Why? |
| Practice Patterns, Physicians' | 1 | 2019 | 4927 | 0.20 | Why? |
| Calreticulin | 1 | 2019 | 38 | 0.20 | Why? |
| Sarcina | 1 | 2018 | 1 | 0.20 | Why? |
| Granulomatous Mastitis | 1 | 2018 | 8 | 0.20 | Why? |
| Fluorescent Antibody Technique, Direct | 1 | 2019 | 69 | 0.19 | Why? |
| Cryptococcus | 1 | 2019 | 29 | 0.19 | Why? |
| Varicella Zoster Virus Infection | 1 | 2019 | 40 | 0.19 | Why? |
| Sensitivity and Specificity | 7 | 2021 | 22971 | 0.19 | Why? |
| Histoplasma | 1 | 2018 | 42 | 0.18 | Why? |
| Hemochromatosis | 1 | 2017 | 20 | 0.18 | Why? |
| Actinomycosis | 1 | 2017 | 17 | 0.18 | Why? |
| Mycological Typing Techniques | 1 | 2017 | 38 | 0.17 | Why? |
| Nocardia Infections | 1 | 2017 | 37 | 0.17 | Why? |
| Cryptococcosis | 1 | 2019 | 97 | 0.17 | Why? |
| Papanicolaou Test | 1 | 2017 | 65 | 0.17 | Why? |
| Nasal Cavity | 1 | 2003 | 909 | 0.17 | Why? |
| Histoplasmosis | 1 | 2018 | 83 | 0.17 | Why? |
| Unnecessary Procedures | 1 | 2019 | 175 | 0.16 | Why? |
| Histiocytes | 1 | 2017 | 97 | 0.16 | Why? |
| Parasitic Diseases | 1 | 2017 | 84 | 0.16 | Why? |
| Environmental Pollution | 1 | 2020 | 344 | 0.16 | Why? |
| Esophagus | 1 | 2018 | 139 | 0.16 | Why? |
| Staphylococcus aureus | 1 | 2003 | 844 | 0.16 | Why? |
| Anus Neoplasms | 1 | 2017 | 123 | 0.15 | Why? |
| Bacterial Typing Techniques | 1 | 2017 | 273 | 0.15 | Why? |
| Nontuberculous Mycobacteria | 1 | 2017 | 114 | 0.15 | Why? |
| Patients' Rooms | 1 | 2020 | 675 | 0.15 | Why? |
| Mycobacterium | 1 | 2017 | 143 | 0.15 | Why? |
| Transplantation Conditioning | 1 | 2017 | 323 | 0.14 | Why? |
| Inservice Training | 1 | 2019 | 477 | 0.14 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2018 | 323 | 0.14 | Why? |
| Mycobacterium Infections, Nontuberculous | 1 | 2017 | 167 | 0.14 | Why? |
| Carcinoma | 1 | 2017 | 256 | 0.14 | Why? |
| Myeloproliferative Disorders | 1 | 2019 | 507 | 0.14 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.13 | Why? |
| Preoperative Care | 1 | 2003 | 1515 | 0.12 | Why? |
| Blood Cell Count | 1 | 2019 | 1101 | 0.12 | Why? |
| Withholding Treatment | 1 | 2019 | 798 | 0.12 | Why? |
| Graft vs Host Disease | 1 | 2017 | 501 | 0.12 | Why? |
| Gene Amplification | 1 | 2012 | 85 | 0.12 | Why? |
| Mycobacterium avium Complex | 1 | 2012 | 61 | 0.12 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 11367 | 0.12 | Why? |
| Mycobacterium avium-intracellulare Infection | 1 | 2012 | 59 | 0.11 | Why? |
| Leukocytes | 1 | 2019 | 1046 | 0.11 | Why? |
| Feasibility Studies | 1 | 2021 | 3467 | 0.11 | Why? |
| Humans | 34 | 2021 | 930598 | 0.11 | Why? |
| Carrier State | 1 | 2003 | 2100 | 0.11 | Why? |
| Antimicrobial Stewardship | 1 | 2019 | 931 | 0.11 | Why? |
| Metagenomics | 1 | 2017 | 823 | 0.11 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2019 | 1439 | 0.10 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.10 | Why? |
| Gastrointestinal Tract | 1 | 2017 | 1113 | 0.10 | Why? |
| Ohio | 2 | 2020 | 639 | 0.10 | Why? |
| Brain | 1 | 2006 | 5133 | 0.09 | Why? |
| Electronic Health Records | 2 | 2019 | 3492 | 0.09 | Why? |
| Kinetics | 1 | 2017 | 3238 | 0.09 | Why? |
| Medical Staff, Hospital | 1 | 2019 | 1258 | 0.09 | Why? |
| DNA, Bacterial | 1 | 2012 | 835 | 0.09 | Why? |
| Chromogenic Compounds | 1 | 2006 | 10 | 0.08 | Why? |
| Algorithms | 3 | 2017 | 7346 | 0.08 | Why? |
| Anti-Bacterial Agents | 2 | 2019 | 10083 | 0.08 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.08 | Why? |
| Hematologic Neoplasms | 1 | 2019 | 2105 | 0.07 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.07 | Why? |
| Eye Infections, Bacterial | 1 | 2006 | 86 | 0.07 | Why? |
| Software | 1 | 2017 | 2501 | 0.07 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.07 | Why? |
| In Situ Hybridization | 1 | 2006 | 390 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.07 | Why? |
| Praziquantel | 1 | 2003 | 44 | 0.07 | Why? |
| Mupirocin | 1 | 2003 | 22 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2017 | 11304 | 0.06 | Why? |
| Thoracotomy | 1 | 2003 | 85 | 0.06 | Why? |
| Emergency Service, Hospital | 2 | 2019 | 14232 | 0.06 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.06 | Why? |
| Anthelmintics | 1 | 2003 | 104 | 0.06 | Why? |
| Gastrointestinal Diseases | 1 | 2017 | 2580 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Conjunctivitis | 1 | 2006 | 318 | 0.06 | Why? |
| Meningitis | 1 | 2004 | 163 | 0.06 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.06 | Why? |
| Bone Marrow Transplantation | 2 | 2017 | 343 | 0.06 | Why? |
| Hemoptysis | 1 | 2003 | 172 | 0.05 | Why? |
| Retrospective Studies | 8 | 2020 | 105322 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.05 | Why? |
| Clothing | 1 | 2020 | 100 | 0.05 | Why? |
| Adult | 7 | 2021 | 244371 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Ultrasonography, Mammary | 1 | 2018 | 31 | 0.05 | Why? |
| Pneumonia | 1 | 2019 | 5652 | 0.05 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.05 | Why? |
| North America | 1 | 2003 | 1400 | 0.05 | Why? |
| Mutation | 1 | 2019 | 12376 | 0.05 | Why? |
| Hospitals, Veterans | 1 | 2020 | 229 | 0.05 | Why? |
| Female | 10 | 2021 | 380317 | 0.05 | Why? |
| Male | 9 | 2021 | 367725 | 0.05 | Why? |
| DNA Primers | 1 | 2003 | 1170 | 0.05 | Why? |
| Hemochromatosis Protein | 1 | 2017 | 21 | 0.05 | Why? |
| Actinomyces | 1 | 2017 | 14 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.05 | Why? |
| Nocardia | 1 | 2017 | 21 | 0.04 | Why? |
| Cytodiagnosis | 1 | 2019 | 104 | 0.04 | Why? |
| Melphalan | 1 | 2017 | 46 | 0.04 | Why? |
| Biopsy, Fine-Needle | 1 | 2018 | 274 | 0.04 | Why? |
| Photopheresis | 1 | 2017 | 33 | 0.04 | Why? |
| Vidarabine | 1 | 2017 | 59 | 0.04 | Why? |
| Thoracic Surgical Procedures | 1 | 2003 | 504 | 0.04 | Why? |
| Antibiotics, Antitubercular | 1 | 2017 | 65 | 0.04 | Why? |
| Aged | 4 | 2021 | 215776 | 0.04 | Why? |
| Alemtuzumab | 1 | 2017 | 121 | 0.04 | Why? |
| Sequence Analysis, DNA | 2 | 2017 | 2830 | 0.04 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.04 | Why? |
| Immunocompromised Host | 1 | 2012 | 5150 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Mycophenolic Acid | 1 | 2017 | 383 | 0.04 | Why? |
| Base Sequence | 1 | 2003 | 3581 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.03 | Why? |
| Genetic Diseases, X-Linked | 1 | 2017 | 237 | 0.03 | Why? |
| Databases, Nucleic Acid | 1 | 2017 | 272 | 0.03 | Why? |
| Antibiotic Prophylaxis | 1 | 2017 | 399 | 0.03 | Why? |
| Prospective Studies | 1 | 2019 | 43301 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Abdomen | 1 | 2017 | 424 | 0.03 | Why? |
| Fixatives | 1 | 2012 | 20 | 0.03 | Why? |
| Cost-Benefit Analysis | 1 | 2003 | 2259 | 0.03 | Why? |
| Cyclosporine | 1 | 2017 | 449 | 0.03 | Why? |
| Quality Control | 1 | 2017 | 628 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| False Positive Reactions | 1 | 2018 | 1338 | 0.03 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.03 | Why? |
| Immune System Diseases | 1 | 2017 | 410 | 0.03 | Why? |
| Tissue Fixation | 1 | 2012 | 85 | 0.03 | Why? |
| Paraffin Embedding | 1 | 2012 | 105 | 0.03 | Why? |
| Formaldehyde | 1 | 2012 | 135 | 0.03 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.03 | Why? |
| Program Evaluation | 1 | 2019 | 1929 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.03 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.02 | Why? |
| Genome, Viral | 2 | 2021 | 13157 | 0.02 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.02 | Why? |
| Lung | 1 | 2017 | 31049 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.02 | Why? |
| Endoscopy | 1 | 2018 | 1564 | 0.02 | Why? |
| Case-Control Studies | 1 | 2006 | 17671 | 0.02 | Why? |
| Workflow | 1 | 2017 | 2373 | 0.02 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Graft Rejection | 1 | 2017 | 1766 | 0.02 | Why? |
| Antiviral Agents | 1 | 2019 | 41703 | 0.02 | Why? |
| Diarrhea | 1 | 2017 | 2743 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.02 | Why? |
| Biopsy | 1 | 2012 | 2811 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.02 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2017 | 1969 | 0.01 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.01 | Why? |
| Computational Biology | 1 | 2017 | 4514 | 0.01 | Why? |
| Prevalence | 1 | 2003 | 25773 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.01 | Why? |
| Child, Preschool | 2 | 2012 | 36283 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 9335 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.01 | Why? |
| Animals | 1 | 2003 | 78931 | 0.01 | Why? |
| Acute Disease | 1 | 2006 | 6029 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
| Infant, Newborn | 1 | 2006 | 23105 | 0.00 | Why? |
| Infant | 1 | 2006 | 30274 | 0.00 | Why? |
| Child | 1 | 2006 | 70012 | 0.00 | Why? |
Procop's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(214)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(77)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_